rs371350653
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001346142.1(AKR1B1):c.-347C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000103 in 1,614,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001346142.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKR1B1 | NM_001628.4 | c.86C>T | p.Thr29Ile | missense_variant | Exon 2 of 10 | ENST00000285930.9 | NP_001619.1 | |
AKR1B1 | NM_001346142.1 | c.-347C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 2 of 10 | NP_001333071.1 | |||
AKR1B1 | NM_001346142.1 | c.-347C>T | 5_prime_UTR_variant | Exon 2 of 10 | NP_001333071.1 | |||
AKR1B1 | NR_144376.2 | n.124C>T | non_coding_transcript_exon_variant | Exon 2 of 9 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251318Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135850
GnomAD4 exome AF: 0.000107 AC: 157AN: 1461864Hom.: 0 Cov.: 32 AF XY: 0.000105 AC XY: 76AN XY: 727230
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.86C>T (p.T29I) alteration is located in exon 2 (coding exon 2) of the AKR1B1 gene. This alteration results from a C to T substitution at nucleotide position 86, causing the threonine (T) at amino acid position 29 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at